Valoración de beta-HCG, estradiol y progesterona en mujeres portadoras de DIU

Article information

Resumen

Objetivo

Se pretende investigar una posible alteración del ciclo ovárico en mujeres portadoras de dispositivo intrauterino (DIU), al mismo tiempo que se intenta averiguar mediante el estudio de la beta-HCG si estos dispositivos son abortivos

Material y método

Se estudian tres grupos. El primero compuesto por 103 mujeres portadoras de DIU, el segundo por 300 mujeres que utilizaban un método de barrera, y el tercero por 300 mujeres que deseaban gestación y no utilizaban método anticonceptivo. En todos ellos se determinaron los valores de progesterona y estradiol en la fase lútea, así como la beta-HCG sérica

Resultados

En el grupo I no se detectó ninguna beta-HCG positiva, frente a un caso en el grupo II y 57 en el grupo III. No se encontraron diferencias significativas respecto a la determinación del estradiol y de la progesterona

Conclusiones

De los hallazgos de nuestro estudio no podemos concluir que la acción anticonceptiva del DIU se produzca durante el ciclo ovárico, no existiendo tampoco fecundación, por lo que se descarta también la acción abortiva

Palabras clave:

DIU

Beta-HCG

Estradiol

Progesterona

Evaluation of beta-human chorionic gonadotrophin, estradiol and progesterone in women with intrauterine devices

Objective

To investigate a possible modification of ovarian cicle in women with intrauterine device (IUD) and to determine with beta-HCG measurements if abortion is one of the mechanisms of IUD

Subjects and method

We study three groups: first composed of 103 women with IUD; second composed of 300 women using barrier methos, and third composed of 300 women without contraceptive method. In all cases serum beta-HCG, progesterine and estradiol were determined in luteal phase

Results

In group I beta-HCG was not detected in any case, one case in group II and 57 in group III. No significative diferences were found concerning estradiol and progesterine determinations

Conclusions

From our findings we can't conclude a contraceptive action of IUD on the level of ovarian cicle. Abortive action is rejected too because there is no fecundation

Keywords:

IUD

Beta-HCG

Estradiol

Progesterone

Full text is only aviable in PDF

Bibliografía

[1.]

M. Hankkamacy, et al.

The effect of the Cooper-T IUD on the luteal phase plasma progesterone concentration in the normal menstrual cycle.

Ann Clin Res, 6 (1974), pp. 40-44

Medline

[2.]

A. Faundes, S. Segal, C. Adejuwon.

The menstrual cycle in woman using and intrauterine device.

Fertil steril, 34 (1980), pp. 427-430

Medline

[3.]

K. Nygren, E. Johansson.

Premature onset of menstrual bleding during ovulatory cycles un women and intrauterine contraceptive device.

Am J Obstet Gynecol, 117 (1973), pp. 971

Medline

[4.]

M. Ortiz, H. Croxatto.

The mode of action of IUDs.

Contraception, 36 (1987), pp. 37-53

Medline

[5.]

M. Eissa, R. Sparks, J. Newton.

Serum and cervical mucus inmunoglobulin levis in copperwire IUD bearers.

Contraception, 32 (1985), pp. 67-75

[6.]

P. Manganiello, S. Nazian, J. Ellegod, P. McDonough, V. Mahesh.

Serum progesterone 17-hydroxyprogesterone, human chorionic gonadotropin, and prolactin in early pregnancy and a case of spontaneous abortion.

Fertil Steril, 36 (1981), pp. 55-60

Medline

[7.]

L. Margulies.

Intrauterine contraceptions: a new approach.

Obstet Ginecol, 24 (1964), pp. 515

[8.]

A. Scommegna, T. Avila, T. Luna, D. Rad, W. Dmoowky.

Fertility control by intrauterine release of progesterone.

Obstet Gynecol, 43 (1974), pp. 769

Medline

[9.]

E. Nutting, P. Hackett, R. Ranney.

Uterine Cooper distribution in monkeys implanted with Copper carryng intrauterine devices.

Fertil Steril, 26 (1975), pp. 80-92

Medline

[10.]

T. Tamaya, Y. Nakata, Y. Ohno.

The mecanism of action of the Copper intrauterine device.

Fertil Steril, 27 (1976), pp. 767-772

Medline

[11.]

C. Nilsson, P. Iahteenmaki, T. Luukkainen.

Levonorgestrel plasma concentration and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.

Contraception, 21 (1980), pp. 223-225

[12.]

J. Parrilla, L. Abad, Y. Gordon, J. López-Bernal, J. Martos.

Determinación de la subunidad beta de la HCG en mujeres portadoras de DIU.

Rev Espas Obstet Gynecol, 38 (1979), pp. 468-470

[13.]

A. Thomas, M. Klein, R. Daniel, J. Mishell.

Absence of circulating chorionic gonadotropin in wearers of intrauterine contraceptives devices.

Am J Obstet Gynecol, 129 (1977), pp. 626

Medline

[14.]

T. Klein, D. Mishell.

Absence of circulating gonadotropin in wears of intrauterine contraceptive devices.

Am J Obstet Gynecol, 129 (1977), pp. 626

Medline

[15.]

R. Sharpe, W. Wrixon, B. Hobson, C. Corker, H. McLeand, R. Short.

Abscencse of HCG-like activity in the blood of women fitted with intrauterine contraceptive devices.

J Clin Endocrinol Metab, 45 (1977), pp. 496

http://dx.doi.org/10.1210/jcem-45-3-496 | Medline

[16.]

J. Allen, M. Wilcox, R. Clarice, R. Canfield.

Urinary human chorionic gonadotropin among intrauterine device users detection with a higly specific and sensitive assay.

Fertil Steril, 45 (1986), pp. 165-169

[17.]

A. Wilcox, C. Weinberg, E. Armstrong, R. Canfield.

Urinary human chorionic gonadotropin among intrauterine device users.

Fertil Steril, 47 (1987), pp. 265-269

Medline

[18.]

L. Tamnsen, P. Eneroth.

Serum levels of pregnancy-specific beta 1-glycoprotein (SP) and human chorionic gonadotropin in women using and intrauterine device.

Contraception, 33 (1986), pp. 497-501

Medline

Indexed in:

Follow us:

Indexed in:

Follow us:

Subscribe to our newsletter